The scientific programme covers the latest advances in gastric cancer, which include areas in Phenotypic Strategies to improve Gastric Cancer Outcomes, Precision Therapy in Gastric Cancer, Clinical Trials Update, Peritoneal Carcinomatosis, Pre-malignant Lesions / Early Detection, Stem Cells and Cancer in Stomach, as well as GEnetics and Epigenetics of GI Malignancies. The SGCC is a translation research group comprising clinicians and scientists working with the aim of improving outcomes for gastric cancer patients.
The conference will bring together world-renowned researches and clinicians to discuss the latest developments in gastroenterological treatment and resaerch, and provide a platform for scientists, surgeons, oncologists, gastroentereologists and primary healthcare physicians in related fields to share their experiences and form exciting new collaborations.